A series of 20 pentamidine analogs were prepared using 2 general Schemes that evaluated heteroatoms, sulfobenzene and alkanediamide groups in the aliphatic linker and methoxy substituents attached to the benzene rings for efficacy against the fungal pathogen, Pneumocystis carinii in an ATP bioassay. All but one of the 20 bisamidines reduced the ATP content of the P. carinii over the 72 h of the assay period. The highest activities were associated with the lack of methoxy groups and the presence of the O, N and S heteroatoms. Activity (IC(50)) for compounds 1, 5, 6, 10 ranged from 1.1 to 2.13 μM. The compound 11 with similar activity (1.33 μM), bears a sulfobenzene group at a nitrogen in the aliphatic linker. The alkanediamide-linked bisbenzamidines showed a moderate inhibition of ATP. Generally, the inclusion of a heteroatom in the aliphatic linker and absence of methoxy groups at the benzene rings were associated with higher activities in this assay. Of note, most of the compounds had little to no cytotoxicity in mammalian cell cultures. Although not quite as potent as other pentamidine derivatives, these compounds hold promise for decreased side effects within the mammalian host.
A series of 20 pentamidine analogs were prepared using 2 general Schemes that evaluated heteroatoms, n class="Chemical">sulfobenzene and alkanediamide groups in the aliphatic linker and methoxy substituents attached to the benzene rings for efficacy against the fungal pathogen, Pneumocystis carinii in an ATP bioassay. All but one of the 20 bisamidines reduced the ATP content of the P. carinii over the 72 h of the assay period. The highest activities were associated with the lack of methoxy groups and the presence of the O, N and S heteroatoms. Activity (IC(50)) for compounds 1, 5, 6, 10 ranged from 1.1 to 2.13 μM. The compound 11 with similar activity (1.33 μM), bears a sulfobenzene group at a nitrogen in the aliphatic linker. The alkanediamide-linked bisbenzamidines showed a moderate inhibition of ATP. Generally, the inclusion of a heteroatom in the aliphatic linker and absence of methoxy groups at the benzene rings were associated with higher activities in this assay. Of note, most of the compounds had little to no cytotoxicity in mammalian cell cultures. Although not quite as potent as other pentamidine derivatives, these compounds hold promise for decreased side effects within the mammalian host.
Authors: I Francesconi; W D Wilson; F A Tanious; J E Hall; B C Bender; R R Tidwell; D McCurdy; D W Boykin Journal: J Med Chem Date: 1999-06-17 Impact factor: 7.446
Authors: Tien L Huang; Jean Jacques Vanden Eynde; Annie Mayence; Margaret S Collins; Melanie T Cushion; Donna Rattendi; Indira Londono; Lakshman Mazumder; Cyrus J Bacchi; Nigel Yarlett Journal: Bioorg Med Chem Lett Date: 2009-08-23 Impact factor: 2.823
Authors: Michael L Berger; Dorota Maciejewska; Jean Jacques Vanden Eynde; Madhusoodanan Mottamal; Jerzy Żabiński; Paweł Kaźmierczak; Mateusz Rezler; Ivana Jarak; Ivo Piantanida; Grace Karminski-Zamola; Annie Mayence; Patrick Rebernik; Arvind Kumar; Mohamed A Ismail; David W Boykin; Tien L Huang Journal: Bioorg Med Chem Date: 2015-06-14 Impact factor: 3.641
Authors: Teresa Żołek; Muge Qile; Paweł Kaźmierczak; Meye Bloothooft; Marcel A G van der Heyden; Dorota Maciejewska Journal: RSC Adv Date: 2019-12-02 Impact factor: 3.361
Authors: D Maciejewska; J Żabiński; M Rezler; P Kaźmierczak; M S Collins; L Ficker; M T Cushion Journal: Medchemcomm Date: 2017-10-05 Impact factor: 3.597
Authors: Melanie T Cushion; Margaret S Collins; Thomas Sesterhenn; Aleksey Porollo; Anish Kizhakkekkara Vadukoot; Edward J Merino Journal: MBio Date: 2016-12-13 Impact factor: 7.867